Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 126 Results Clear All
NOMIS–Gladstone Fellow Cathrine Sant is studying an enigmatic region of the human genome linked to neurodegenerative disease risk.
Neurological Disease NOMIS Graduate Students and Postdocs Profile
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News Release
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease
Gladstone scientists have developed a thinking microscope powered by artificial intelligence.
AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS
The prize honors scientists whose breakthroughs in brain research have high potential for patient impact.
Philanthropy Awards News Release Alzheimer’s Disease Neurological Disease Yang Lab
Gladstone scientists developed a new tool to trace how the brain clears “waste,” uncovering surprising new biology about how it keeps itself healthy.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Yang Lab
The prize, issued annually to eight scientists, seeks to catalyze high-impact neuroscience research.
Awards News Release Alzheimer’s Disease Neurological Disease Corces Lab AI
New findings on the APOE4 gene variant point to a potential therapeutic target for Alzheimer’s disease.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Aging Human Genetics
Scientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
Gladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
The AI Journal—A collaboration between Topos Bio and the team led by Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, aims to apply a new approach to neurodegenerative disease.
Gladstone Experts Alzheimer’s Disease Neurological Disease Finkbeiner Lab
Scientists at Gladstone show the new method could treat the majority of patients with Charcot-Marie-Tooth disease.
News Release Research (Publication) Neurological Disease Conklin Lab CRISPR/Gene Editing
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab
Earth.com—A study by Gladstone Investigator Ken Nakamura helps answer a long-standing debate about Parkinson’s disease: do the cell’s tiny energy factories fail first and spark the disorder, or do they crumble only after brain cells have already begun to die?
Gladstone Experts Parkinson’s Disease Neurological Disease Nakamura Lab
Inside Precision Medicine—A new study by Gladstone Investigator Ken Nakamura has found that a mitochondrial protein, CHCHD2, can drive a sequence of cellular events that lead to the development Parkinson’s disease.
Gladstone Experts Parkinson’s Disease Neurological Disease Nakamura Lab
